Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Free Report) – Equities research analysts at Seaport Res Ptn dropped their Q1 2025 earnings per share estimates for Curaleaf in a research report issued on Wednesday, March 5th. Seaport Res Ptn analyst S. Randhawa now anticipates that the company will earn ($0.07) per share for the quarter, down from their prior forecast of ($0.06). The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Seaport Res Ptn also issued estimates for Curaleaf’s Q4 2025 earnings at ($0.05) EPS and FY2025 earnings at ($0.24) EPS.
Curaleaf (OTCMKTS:CURLF – Get Free Report) last posted its earnings results on Monday, March 3rd. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.09. Curaleaf had a negative return on equity of 13.67% and a negative net margin of 14.82%. The company had revenue of $331.05 million for the quarter, compared to the consensus estimate of $331.87 million.
Curaleaf Stock Down 3.0 %
Curaleaf Company Profile
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Recommended Stories
- Five stocks we like better than Curaleaf
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What does consumer price index measure?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.